“I’m happy those who attended my DIA Global presentation said that as a result they had confidence in the future development of the landscape of these markets and felt they had gained new insights and strategies from my presentation’s topic concerning challenges and opportunities of enrolling patients in clinical trials in Latin America,” said Tylosky. “It’s important for anyone considering a clinical trial to know that Latin American is a region of 660 million people and it is a land of opportunity for clinical research and market access with an epidemiological profile resembling that of the Unites States. Navigating the unique cultural and logistical challenges of Latin America and emerging markets is our specialty.”
Tylosky will be happy to provide this presentation with necessary customization to your organization. Contact info: Sara Tylosky, CEO Farmacon Global